Incidence and risk factors for recurrence of endocrinopathic laminitis in horses
- PMID: 30972832
- PMCID: PMC6524073
- DOI: 10.1111/jvim.15497
Incidence and risk factors for recurrence of endocrinopathic laminitis in horses
Abstract
Background: Endocrinopathic laminitis is common in horses and ponies, but the recurrence rate of the disease is poorly defined.
Objectives: To determine the incidence of, and risk factors for, the recurrence of endocrinopathic laminitis.
Animals: Privately owned horses and ponies with acute laminitis (n = 317, of which 276 cases with endocrinopathic laminitis were followed up to study completion).
Methods: This prospective cohort study collected data on veterinary-diagnosed cases of acute laminitis for 2 years. Each case was classified on acceptance to the study as endocrinopathic or non-endocrinopathic using data collected in a questionnaire completed by the animal's veterinarian. Follow-up data were collected at regular intervals to determine whether the laminitis recurred in the 2-year period after diagnosis.
Results: The recurrence rate for endocrinopathic laminitis was 34.1%. The risk of recurrence during the 2-year study period increased with basal, fasted serum insulin concentration (P ≤ .05), with the probability of recurrence increasing markedly as the insulin concentration increased beyond the normal range (0-20 μIU/mL) to over the threshold for normal (up to approximately 45 μIU/mL). Being previously diagnosed with laminitis (before the study; P = .05) was also a risk factor for recurrent laminitis. Cases with a higher Obel grade of laminitis were likely (P = .05) to recur sooner.
Conclusions and clinical importance: Knowing that hyperinsulinemia and being previously diagnosed with laminitis are significant risk factors for recurrence will enable clinicians to proactively address these factors, thereby potentially reducing the risk of recurrence of laminitis.
Keywords: ACTH; equine metabolic syndrome; horse; hyperinsulinemia; insulin dysregulation; pituitary pars intermedia dysfunction.
© 2019 The Authors. Journal of Veterinary Internal Medicine published by Wiley Periodicals, Inc. on behalf of the American College of Veterinary Internal Medicine.
Conflict of interest statement
Authors declare no conflict of interest.
Figures
References
-
- Bertin FR, de Laat MA. The diagnosis of equine insulin dysregulation. Equine Vet J. 2017;49:570‐576. - PubMed
-
- Tadros EM, Fowlie JG, Refsal KR, Marteniuk J, Schott HC II. Association between hyperinsulinemia and laminitis severity at the time of pituitary pars intermedia dysfunction diagnosis. Equine Vet J. 2019;51:52‐56. - PubMed
-
- Frank N, Tadros EM. Insulin dysregulation. Equine Vet J. 2014;46:103‐112. - PubMed
-
- Coleman MC, Belknap JK, Eades SC, et al. Case‐control study of risk factors for pasture‐and endocrinopathy‐associated laminitis in North American horses. J Am Vet Med Assoc. 2018;253:470‐478. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
